Cargando…
No Influence of Dopamine System Gene Variations on Acute Effects of MDMA
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is a recreational substance also investigated as medication for posttraumatic stress disorder. Dopamine (DA) system stimulation likely contributes to the acute mood effects of amphetamines, including MDMA. Genetic variants, such as single-nucleotide...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821788/ https://www.ncbi.nlm.nih.gov/pubmed/31708815 http://dx.doi.org/10.3389/fpsyt.2019.00755 |
_version_ | 1783464200794800128 |
---|---|
author | Vizeli, Patrick Liechti, Matthias E. |
author_facet | Vizeli, Patrick Liechti, Matthias E. |
author_sort | Vizeli, Patrick |
collection | PubMed |
description | 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is a recreational substance also investigated as medication for posttraumatic stress disorder. Dopamine (DA) system stimulation likely contributes to the acute mood effects of amphetamines, including MDMA. Genetic variants, such as single-nucleotide polymorphisms (SNPs), and polymorphic regions of the DA system genes may in part explain interindividual differences in the acute responses to MDMA in humans. We characterized the effects of common genetic variants within genes coding for key players in the DA system including the dopamine D2 receptor (DRD2/ANKK1 rs1800497, DRD2 rs6277, and rs107959), the dopamine transporter (DAT1 rs28363170, rs3836790, rs6347, rs11133767, rs11564774, rs460000, and rs463379), and dopamine D4 receptor [DRD4, variable-number tandem repeat (VNTR)] on the subjective and autonomic response to MDMA (125 mg) in pooled data from randomized, placebo-controlled, crossover studies in a total of 149 healthy subjects. Plasma concentrations of MDMA were used as covariate in the analysis to control for individual pharmacokinetic (metabolic and weight) differences. None of the tested genetic polymorphisms within the DA system altered effects of MDMA when adjusting for multiple comparisons. Genetic variations in genes coding for players of the DA system are unlikely to explain interindividual variations in the acute effects of MDMA in humans. |
format | Online Article Text |
id | pubmed-6821788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68217882019-11-08 No Influence of Dopamine System Gene Variations on Acute Effects of MDMA Vizeli, Patrick Liechti, Matthias E. Front Psychiatry Psychiatry 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is a recreational substance also investigated as medication for posttraumatic stress disorder. Dopamine (DA) system stimulation likely contributes to the acute mood effects of amphetamines, including MDMA. Genetic variants, such as single-nucleotide polymorphisms (SNPs), and polymorphic regions of the DA system genes may in part explain interindividual differences in the acute responses to MDMA in humans. We characterized the effects of common genetic variants within genes coding for key players in the DA system including the dopamine D2 receptor (DRD2/ANKK1 rs1800497, DRD2 rs6277, and rs107959), the dopamine transporter (DAT1 rs28363170, rs3836790, rs6347, rs11133767, rs11564774, rs460000, and rs463379), and dopamine D4 receptor [DRD4, variable-number tandem repeat (VNTR)] on the subjective and autonomic response to MDMA (125 mg) in pooled data from randomized, placebo-controlled, crossover studies in a total of 149 healthy subjects. Plasma concentrations of MDMA were used as covariate in the analysis to control for individual pharmacokinetic (metabolic and weight) differences. None of the tested genetic polymorphisms within the DA system altered effects of MDMA when adjusting for multiple comparisons. Genetic variations in genes coding for players of the DA system are unlikely to explain interindividual variations in the acute effects of MDMA in humans. Frontiers Media S.A. 2019-10-24 /pmc/articles/PMC6821788/ /pubmed/31708815 http://dx.doi.org/10.3389/fpsyt.2019.00755 Text en Copyright © 2019 Vizeli and Liechti http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Vizeli, Patrick Liechti, Matthias E. No Influence of Dopamine System Gene Variations on Acute Effects of MDMA |
title | No Influence of Dopamine System Gene Variations on Acute Effects of MDMA |
title_full | No Influence of Dopamine System Gene Variations on Acute Effects of MDMA |
title_fullStr | No Influence of Dopamine System Gene Variations on Acute Effects of MDMA |
title_full_unstemmed | No Influence of Dopamine System Gene Variations on Acute Effects of MDMA |
title_short | No Influence of Dopamine System Gene Variations on Acute Effects of MDMA |
title_sort | no influence of dopamine system gene variations on acute effects of mdma |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821788/ https://www.ncbi.nlm.nih.gov/pubmed/31708815 http://dx.doi.org/10.3389/fpsyt.2019.00755 |
work_keys_str_mv | AT vizelipatrick noinfluenceofdopaminesystemgenevariationsonacuteeffectsofmdma AT liechtimatthiase noinfluenceofdopaminesystemgenevariationsonacuteeffectsofmdma |